Nao Medical

Nao Medical's Mineola location in New York is a REMS-certified facility providing FDA-approved Spravato (esketamine) for eligible adults with treatment-resistant depression and for adults with major depressive disorder experiencing acute suicidal thoughts. As an esketamine nasal spray, Spravato acts on glutamate, offering an option when conventional antidepressants have not provided sufficient relief.

Treatment includes clinical evaluation, benefits verification, prior authorization support, and monitored in-office dosing with an observation period, along with transportation planning for treatment days.

Eligible patients are paired with a dedicated care manager who handles authorization, scheduling, and logistics. The Mineola clinic supports Nassau County demand for monitored Spravato treatment, accepting major insurance including Medicaid and Medicare.